Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Benitec Biopharma Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 21 | 17 | −4 |
| Shares | 11.6M | 11.1M | −577.5K (−5.0%) |
| Value | $2.44M | $2.45M | +$11.3K (+0.5%) |
New holders (1)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhumbline Advisers | 3,161 | $752 | 0.00% |
Sold out (5)
Institutions that held Benitec Biopharma Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Renaissance Technologies LLC | 224,879 | $47.0K |
| Walleye Capital LLC | 215,989 | $45.3K |
| Two Sigma Investments, LP | 26,747 | $5.61K |
| Cantor Fitzgerald, L. P. | 25,050 | $5.26K |
| Cetera Advisor Networks LLC | 12,351 | $2.59K |